Puma Biotechnology reported $136.92M in Current Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Acceleron Pharma XLRN:US $ 696.61M 21.16M
Agios Pharmaceuticals AGIO:US $ 1305.29M 397.28M
Alexion Pharmaceuticals ALXN:US $ 6452.6M 619.6M
Alnylam Pharmaceuticals ALNY:US $ 2675.36M 49.8M
Amgen AMGN:US $ 24380M 5281M
Arena Pharmaceuticals ARNA:US $ 790.92M 199.52M
Array Technologies Inc ARRY:US 491.62M 161.41M
Biogen BIIB:US $ 7162.3M 21.4M
Biomarin Pharmaceutical BMRN:US $ 2311.57M 46.27M
Bluebird Bio BLUE:US $ 832.32M 71.2M
Cerulean Pharma CERU:US $ 48.24M 34.18M
Clovis Oncology CLVS:US $ 230.67M 65.69M
Daiichi Sankyo 4568:JP Y 1270181M 36484M
Esperion Therapeutics ESPR:US $ 170.67M 104.51M
Exelixis EXEL:US $ 1662.03M 68.78M
Gilead Sciences GILD:US $ 14200M 275M
Glaxosmithkline GSK:US $ 18254M 688M
Macrogenics MGNX:US $ 334.7M 32.3M
Mirati Therapeutics MRTX:US $ 1171.89M 106.2M
Moderna Inc MRNA:US 13.42B 2.46B
Novartis NOVN:VX 26.25B 2.45B
Ptc Therapeutics PTCT:US $ 1011.14M 55.09M
Puma Biotechnology PBYI:US $ 136.92M 30.83M
Regeneron Pharmaceuticals REGN:US $ 13775.4M 437.8M
Sangamo Biosciences SGMO:US $ 447.4M 106.67M
Sarepta Therapeutics SRPT:US $ 2185.31M 79.91M
Seattle Genetics SGEN:US $ 3114.61M 16.1M
Spectrum Pharmaceuticals SPPI:US $ 140M 25.71M
Takeda 4502:JP Y 2456353M 20105M
Ultragenyx Pharmaceutical RARE:US $ 846.88M 102.61M
Vanda Pharmaceuticals VNDA:US $ 461.81M 15.16M
Vertex Pharmaceuticals VRTX:US $ 8852.54M 395.03M
YTE INCY:US $ 2923.8M 303.74M